MedBud is active on Twitter, follow us today for development updates, prescription changes and general info: @MedBudCIC

Back to Noidecs or All Oil Concentrates

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This product was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Medication Details

Brand
United Kingdom Noidecs
Designation
T20:C40
Chemotype
Type II: THC/CBD Mix
THC Potential Range (±10%)
18-22mg
CBD Potential Range (±10%)
36-44mg
Cultivated or Packaged in
Flag of Israel Israel
Imported by
United Kingdom Eaststone

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Discontinued

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Dispensing Patient Pharmacies

Project Twenty21

Available on T21, a research project offering participating patients several discounted medications:

Product DescriptionPatient Reviews

United Kingdom About Lyphe Group Ltd

Noidecs Logo

From Lyphe Group, a range of medical flowers and oils focused on giving doctors reassurance in the efficiency and consistency of our supply chain, while providing quality pharmaceutical-grade medication.

From Lyphe Group, Noidecs provides a range of medical flowers and oils focused on giving doctors reassurance in the efficiency and consistency of our supply chain, while providing quality pharmaceutical-grade medication.

lyphegroup.com

  New government petition approved: Introduce 'Grow Your Own' Laws for Legal Medical Cannabis Patients (CBPM) — please sign and share. 6 months to achieve 10,000 signatures.

  Information provided is partially community-sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)